Seroatlas · Human Serome Atlas

RNASEH1

Ribonuclease H1

Also known as: RNH1_HUMAN

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
O60930
Gene
RNASEH1
Ensembl
ENSG00000171865
Chromosome
2
Canonical length
286 aa
Protein class
Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins
Subcellular location
Nucleoplasm,Cytosol
Secretome location
Intracellular and membrane

OverviewNCBI Gene

This gene encodes an endonuclease that specifically degrades the RNA of RNA-DNA hybrids and plays a key role in DNA replication and repair. Alternate in-frame start codon initiation results in the production of alternate isoforms that are directed to the mitochondria or to the nucleus. The production of the mitochondrial isoform is modulated by an upstream open reading frame (uORF). Mutations in this gene have been found in individuals with progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal recessive 2. Alternative splicing results in additional coding and non-coding transcript variants. Pseudogenes of this gene have been defined on chromosomes 2 and 17. [provided by RefSeq, Jul 2017]

Canonical amino-acid sequenceUniProt

286 residues, UniProt reviewed canonical sequence.

>O60930|RNASEH1
     1  MSWLLFLAHR VALAALPCRR GSRGFGMFYA VRRGRKTGVF LTWNECRAQV DRFPAARFKK
    61  FATEDEAWAF VRKSASPEVS EGHENQHGQE SEAKASKRLR EPLDGDGHES AEPYAKHMKP
   121  SVEPAPPVSR DTFSYMGDFV VVYTDGCCSS NGRRRPRAGI GVYWGPGHPL NVGIRLPGRQ
   181  TNQRAEIHAA CKAIEQAKTQ NINKLVLYTD SMFTINGITN WVQGWKKNGW KTSAGKEVIN
   241  KEDFVALERL TQGMDIQWMH VPGHSGFIGN EEADRLAREG AKQSED

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against RNASEH1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Intracellular
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.4
Highest tissue expression
16 nTPM

Expression across tissuesHPA

Tissue

  • skeletal muscle: 16 nTPM
  • tongue: 14 nTPM
  • cerebellum: 13 nTPM
  • cerebral cortex: 13 nTPM
  • hippocampal formation: 13 nTPM
  • smooth muscle: 12 nTPM

Single-cell type

  • loop of henle epithelial cells: 3.8 nCPM
  • renal collecting duct intercalated cells: 3.6 nCPM
  • renal collecting duct principal cells: 3.6 nCPM
  • proximal tubule cells: 3.4 nCPM
  • renal connecting tubule cells: 3.2 nCPM
  • distal convoluted tubule cells: 2.8 nCPM

Immune cell

  • MAIT T-cell: 2.2 nTPM
  • naive CD8 T-cell: 2.1 nTPM
  • memory CD8 T-cell: 1.7 nTPM
  • plasmacytoid DC: 1.5 nTPM
  • eosinophil: 1.3 nTPM
  • gdT-cell: 1.3 nTPM

Brain region

  • hypothalamus: 22 nTPM
  • hippocampal formation: 21 nTPM
  • cerebral cortex: 20 nTPM
  • basal ganglia: 19 nTPM
  • white matter: 19 nTPM
  • pons: 19 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about RNASEH1.

Disease | AllUniProt

Conditions RNASEH1 is implicated in, by any mechanism.

Disease | GeneticClinVar

6 pathogenic / likely-pathogenic of 240 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.74
gnomAD pLI
0.01
gnomAD missense Z
0.11
DepMap mean gene effect
-0.05
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 8% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads RNASEH1 as an antibody target. Whether an autoantibody or antibody against RNASEH1 could matter depends on whether native RNASEH1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

RNASEH1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label RNASEH1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/RNASEH1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...